These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 10070903)
1. Apoptotic activity is increased in parallel with the metaplasia-dysplasia-carcinoma sequence of the bronchial epithelium. Törmänen U; Nuorva K; Soini Y; Pääkkö P Br J Cancer; 1999 Feb; 79(5-6):996-1002. PubMed ID: 10070903 [TBL] [Abstract][Full Text] [Related]
2. P53 in squamous metaplasia: a marker for risk of respiratory tract carcinoma. Boers JE; ten Velde GP; Thunnissen FB Am J Respir Crit Care Med; 1996 Jan; 153(1):411-6. PubMed ID: 8542151 [TBL] [Abstract][Full Text] [Related]
3. Histopathological analysis of apoptosis, and expression of p53, bcl-2, bax, and Ki-67 in laryngeal squamous cell carcinomas and dysplasia. Izawa H; Yonemitsu N; Shin T; Sugihara H Auris Nasus Larynx; 1999 Jul; 26(3):317-30. PubMed ID: 10419041 [TBL] [Abstract][Full Text] [Related]
4. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung. Shabnam MS; Srinivasan R; Wali A; Majumdar S; Joshi K; Behera D Lung Cancer; 2004 Aug; 45(2):181-8. PubMed ID: 15246189 [TBL] [Abstract][Full Text] [Related]
5. Value of immunohistochemical markers in preinvasive bronchial lesions in risk assessment of lung cancer. Jeanmart M; Lantuejoul S; Fievet F; Moro D; Sturm N; Brambilla C; Brambilla E Clin Cancer Res; 2003 Jun; 9(6):2195-203. PubMed ID: 12796386 [TBL] [Abstract][Full Text] [Related]
6. Expression of Bcl-2, Bax, and p53 proteins in carcinogenesis of squamous cell lung cancer. Chen Y; Sato M; Fujimura S; Endo C; Sakurada A; Aikawa H; Takahashi H; Tanita T; Kondo T; Saito Y; Sagawa M Anticancer Res; 1999; 19(2B):1351-6. PubMed ID: 10365105 [TBL] [Abstract][Full Text] [Related]
7. Recurrence of squamous cell lung carcinoma is associated with the co-presence of reactive lesions in tumor-adjacent bronchial epithelium. Pankova OV; Denisov EV; Ponomaryova AA; Gerashchenko TS; Tuzikov SA; Perelmuter VM Tumour Biol; 2016 Mar; 37(3):3599-607. PubMed ID: 26456960 [TBL] [Abstract][Full Text] [Related]
8. Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small-cell lung cancer. Borner MM; Brousset P; Pfanner-Meyer B; Bacchi M; Vonlanthen S; Hotz MA; Altermatt HJ; Schlaifer D; Reed JC; Betticher DC Br J Cancer; 1999 Feb; 79(5-6):952-8. PubMed ID: 10070896 [TBL] [Abstract][Full Text] [Related]
9. The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue. Xie X; Clausen OP; De Angelis P; Boysen M Cancer; 1999 Sep; 86(6):913-20. PubMed ID: 10491515 [TBL] [Abstract][Full Text] [Related]
10. Cell turnover in apocrine metaplasia and apocrine adenosis of the breast. Elayat G; Selim AG; Wells CA Ann Diagn Pathol; 2010 Feb; 14(1):1-7. PubMed ID: 20123450 [TBL] [Abstract][Full Text] [Related]
11. [Expression of apoptosis-related protein in epithelial dysplasia and squamous cell carcinoma]. Guan W; Yu S; Gao Y Zhonghua Kou Qiang Yi Xue Za Zhi; 2002 Jan; 37(1):65-8. PubMed ID: 11955367 [TBL] [Abstract][Full Text] [Related]
12. Accelerated apoptosis and low bcl-2 expression associated with neuroendocrine differentiation predict shortened survival in operated large cell carcinoma of the lung. Eerola AK; Ruokolainen H; Soini Y; Raunio H; Pääkkö P Pathol Oncol Res; 1999; 5(3):179-86. PubMed ID: 10491014 [TBL] [Abstract][Full Text] [Related]
13. Expression of Bcl-X(L), an antiapoptotic member of the Bcl-2 family, in esophageal squamous cell carcinoma. Torzewski M; Sarbia M; Heep H; Dutkowski P; Willers R; Gabbert HE Clin Cancer Res; 1998 Mar; 4(3):577-83. PubMed ID: 9533524 [TBL] [Abstract][Full Text] [Related]
14. Distribution of proliferating-cell nuclear antigen and epidermal growth factor receptor in intraepithelial squamous cell lesions of human bronchus. Yoneda K Mod Pathol; 1994 May; 7(4):480-6. PubMed ID: 7915034 [TBL] [Abstract][Full Text] [Related]
15. p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck. Lavieille JP; Gazzeri S; Riva C; Reyt E; Brambilla C; Brambilla E Anticancer Res; 1998; 18(6B):4741-9. PubMed ID: 9891551 [TBL] [Abstract][Full Text] [Related]
16. Atypical bronchopulmonary carcinoids show a tendency toward increased apoptotic and proliferative activity. Laitinen KL; Soini Y; Mattila J; Pääkkö P Cancer; 2000 Apr; 88(7):1590-8. PubMed ID: 10738217 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of PCNA, p53, bax and bcl-2 in oral lichen planus and epithelial dysplasia. Sousa FA; Paradella TC; Carvalho YR; Rosa LE J Oral Sci; 2009 Mar; 51(1):117-21. PubMed ID: 19325208 [TBL] [Abstract][Full Text] [Related]
18. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2. Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901 [TBL] [Abstract][Full Text] [Related]
19. Human non-small cell lung cancer: p53 protein accumulation is an early event and persists during metastatic progression. Fontanini G; Vignati S; Bigini D; Merlo GR; Ribecchini A; Angeletti CA; Basolo F; Pingitore R; Bevilacqua G J Pathol; 1994 Sep; 174(1):23-31. PubMed ID: 7965400 [TBL] [Abstract][Full Text] [Related]
20. Expression of the BCL-2 protein in normal and dysplastic bronchial epithelium and in lung carcinomas. Walker C; Robertson L; Myskow M; Dixon G Br J Cancer; 1995 Jul; 72(1):164-9. PubMed ID: 7599047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]